About 4 000 reports

  • MERCK'S MRSA PORTFOLIO ASSESSMENT, 2015
  • GLOBAL SALES FORECASTS ($M) FOR OMADACYCLINE, 2014-2024

PLOS ONE; ##(##): E##.

  • Pharmaceutical
  • World
  • Company
  • Allergan plc
  • Cellceutix Corporation

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Pharmaceutical
  • Switzerland
  • World
  • Company
  • Polyphor Ltd.
  • Arena Pharmaceuticals Inc - Corporate Strategy
  • Arena Pharmaceuticals Inc - Key Employees

Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and...

  • Pharmaceutical
  • United States
  • Company
  • Company Financials
  • Arena Pharmaceuticals, Inc.
  • Ipsen SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
  • Ipsen SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Ipsen SA (Ipsen) is a global specialty biopharmaceutical company that manufactures and distributes drugs for the treatment of cancer and rare and neurological diseases.The company develops and commercializes novel medicines in cancer, neuroscience and rare diseases. It also offers products to treat gastrointestinal...

  • Pharmaceutical
  • France
  • United States
  • Company
  • Ipsen S.A.
  • LEO Pharma A/S - Key Employees
  • LEO Pharma A/S, Key Employees

Summary LEO Pharma A/S (LEO Pharma), a subsidiary of LEO Foundation is a research-based pharmaceutical company.It discovers, develops, manufactures and commercializes pharmaceuticals in therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, eczema, skin infections,...

  • Pharmaceutical
  • United States
  • World
  • Company
  • LEO Pharma A/S

One unit refers to one NPWT canister.

  • Pharmaceutical
  • Company
  • Acelity L.P. Inc.
  • GlobalData's company
  • Invacare Corporation
  • Deal Rationale
  • PLEDPHARMA RAISES USD10 MILLION IN RIGHTS OFFERING OF SHARES

GlobalData PledPharma AB, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • World
  • Company
  • PledPharma AB
  • Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Stallergenes Greer plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Summary Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases.The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important...

  • Pharmaceutical
  • United States
  • World
  • Company
  • Stallergenes Greer plc
  • Pharmaceuticals & Healthcare, Global, Number Of Deals (%), 2017
  • shows the total number and the value of mergers and acquisitions in the pharmaceutical and healthcare

Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals Summary GlobalData’s "Partnerships, Licensing, Investments and M&A Deals and Trends for 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • World
  • Company

Earlier, on November ##, 2013, Ignyta enters into licensing agreement with Nerviano Medical Sciences, for the development of two leading tyrosine kinase inhibitors.

  • Pharmaceutical
  • China
  • Italy
  • Company
  • Nerviano Medical Sciences Srl
  • SERVIER COMPLETES ACQUISITION OF REMAINING 49.09% STAKE IN EGIS PHARMA FOR USD483 MILLION
  • Company Overview

Summary Servier Laboratories SAS (Servier) is a research-based pharmaceutical company that researches, develops, manufactures and markets drugs for treating various diseases.The company’s portfolio of marketed products treat central nervous system disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases,...

  • Pharmaceutical
  • France
  • World
  • Company
  • Les Laboratoires Servier SAS
  • SMITH & NEPHEW PLC, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

Summary Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for use in orthopaedic reconstruction and trauma, sports medicines and advanced wound management.The company offers its products in various categories including Sports Medicine Joint Repair,...

  • Pharmaceutical
  • United Kingdom
  • United States
  • World
  • Company
  • Plc

GlobalData Horizon Discovery Group Plc reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Pharmaceutical
  • United Kingdom
  • United States
  • Company
  • Horizon Discovery
  • Pharmaxis Ltd, Subsidiaries
  • Jun 07, 2017: Pharmaxis Appoints Former Head of Global Research at Merck to Board of Directors

GlobalData Pharmaxis Ltd' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Pharmaxis Ltd

GlobalData TFS International AB, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Pharmaceutical
  • Sweden
  • United States
  • World
  • Company
  • Admedus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Admedus Ltd, Deals By Therapy Area, 2012 to YTD 2018

Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies.Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue repairs. Its flagship...

  • Pharmaceutical
  • Australasia
  • Australia
  • Company
  • Admedus Ltd
  • IXICO Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs.The company offers products such as assessa, trial tracker, trialwire and mehealth. It provides web-based platform to transfer...

  • Pharmaceutical
  • United Kingdom
  • World
  • Company
  • IXICO plc

GlobalData Region Asia-Pacific Europe North America Middle East and Africa South and Central America No. of Deals ## ## ## NA NA Deal Value (US$ million) ##. ## NA ##. ## NA NA Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 Prop

  • Biopharmaceutical
  • Pharmaceutical
  • World
  • Company
  • BioPharma company
  • URL: WWW.FCC.CO.ZA
  • URL: WWW.FCC.CO.ZA

Normalised EBITDA ## improved ##% to R##, ## billion.

  • Pharmaceutical
  • Australasia
  • Australia
  • Company
  • Aspen Pharmacare Holdings Limited
  • AGENTS IN PHASE I OR EARLY PHASE II CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B
  • OTHER AGENTS IN CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B TREATMENT, 2015

ua=##& ua=##.

  • Pharmaceutical
  • United States
  • Company
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • C shows licensing deal values varied considerably by year. The highest total values were
  • D shows that 43% of deals, with the exception of 36 deals where the product's stage of

Experimental Neurobiology; ##(##):##-## Intec Pharma (2015).

  • Pharmaceutical
  • World
  • Company
  • Novartis AG
  • Parkinson Study Group
  • 4.10.1 Company Overview

Each catheter set comes along with one cannula, one catheter, and one obturator.

  • Pharmaceutical
  • China
  • Company
  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • NOW Foods expands to new facility in Roselle Date : 17 Nov 2015

DSM Nutritional Products, Inc. provides products and services for food, personal care and pharmaceutical industries and has presence in various countries.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Demand
  • AGENTS IN PHASE I OR EARLY PHASE II CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B
  • OTHER AGENTS IN CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B TREATMENT, 2015

ua=##& ua=##.

  • Pharmaceutical
  • Japan
  • Company
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • AGENTS IN PHASE I OR EARLY PHASE II CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B
  • OTHER AGENTS IN CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B TREATMENT, 2015

ua=##& ua=##.

  • Pharmaceutical
  • China
  • Company
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • Daewoong Pharmaceutical Co., Ltd. - History
  • Daewoong Pharmaceutical Co., Ltd., History

Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities...

  • Pharmaceutical
  • South Korea
  • World
  • Company
  • Daewoong Pharma
  • VIIV HEALTHCARE LTD, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2011 TO YTD 2017
  • VIIV HEALTHCARE ANNOUNCES LICENSING AGREEMENT FOR CELSENTRI

Summary ViiV Healthcare Ltd (ViiV), formerly Glaxosmithkline Newco Ltd, a subsidiary of GlaxoSmithKline Plc, is a researcher and developer of HIV medicines. The company provides nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitor, protease inhibitors, and CCR5 antagonist for the treatment of...

  • Pharmaceutical
  • United Kingdom
  • United States
  • Company
  • ViiV Healthcare Ltd.
  • Color Scheme: Trial Status): Grey: Completed; Blue: Ongoing but not Recruiting
  • PEFICITINIB: PHASE III CLINICAL DEVELOPMENT PROGRAM

TWITTER IS ONE OF THE MOST POPULAR PLATFORMS WHEREIN THOUSANDS OF INDIVIDUALS FOLLOW SEVERAL PHARMACEUTICAL COMPANIES.

  • Pharmaceutical
  • North America
  • United States
  • Company
  • AbbVie Inc.
  • Amryt Pharma plc, Key Employees
  • Feb 09, 2017: Amryt Pharma Announces Directorate Change

Summary Amryt Pharma plc (Amryt), formerly Fastnet Equity plc is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases.The company’s lead product, Episalvan (betulin), is approved in Europe for the treatment of partial-thickness wounds...

  • Pharmaceutical
  • Europe
  • United States
  • Company
  • Amryt Pharma plc
  • MERZ PHARMA GMBH & CO KGAA, SUBSIDIARIES
  • MERZ PHARMA GMBH & CO KGAA - KEY EMPLOYEES

Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders.The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous system, skin and hair...

  • Pharmaceutical
  • North America
  • United States
  • Company
  • Merz Pharmaceuticals GmbH